Valerie Haley
YOU?
Author Swipe
View article: Table of Contents
Table of Contents Open
View article: Candida auris admission screening pilot in select units of New York City health care facilities, 2017-2019
Candida auris admission screening pilot in select units of New York City health care facilities, 2017-2019 Open
View article: Dealing with highly skewed hospital length of stay distributions: The use of Gamma mixture models to study delivery hospitalizations
Dealing with highly skewed hospital length of stay distributions: The use of Gamma mixture models to study delivery hospitalizations Open
The increased focus on addressing severe maternal morbidity and maternal mortality has led to studies investigating patient and hospital characteristics associated with longer hospital stays. Length of stay (LOS) for delivery hospitalizati…
View article: Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018: Impact and Lessons Learned
Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018: Impact and Lessons Learned Open
Candida auris is a multidrug-resistant yeast which has emerged in health care facilities worldwide; however, little is known about identification methods, patient colonization, environmental survival, spread, and drug resistance. Colonizat…
View article: Laboratory Analysis of an Outbreak of <i>Candida auris</i> in New York from 2016 to 2018-Impact and Lessons Learned
Laboratory Analysis of an Outbreak of <i>Candida auris</i> in New York from 2016 to 2018-Impact and Lessons Learned Open
Candida auris is a multidrug-resistant yeast which has emerged in healthcare facilities worldwide, however little is known about identification methods, patient colonization, spread, environmental survival, and drug resistance. Colonizatio…
View article: 384. Findings From a <i>Candida auris</i> Admission Screening Pilot in New York State
384. Findings From a <i>Candida auris</i> Admission Screening Pilot in New York State Open
BACKGROUND: Candida auris is an emerging multidrug-resistant yeast which can spread within healthcare facilities and is associated with significant morbidity. Over 160 clinical cases have been reported in NYS. This pilot aims to assess the…
View article: 2039. New York State 2016–2018: Progression from <i>Candida auris</i> Colonization to Bloodstream Infection
2039. New York State 2016–2018: Progression from <i>Candida auris</i> Colonization to Bloodstream Infection Open
BACKGROUND: New York State (NYS) is experiencing a continuing outbreak of Candida auris, first identified in 2016. Patients who are colonized asymptomatically with C. auris can progress to bloodstream infection (BSI). METHODS: Colonized pa…
View article: 385. The Value Added From <i>Candida auris</i> Point Prevalence and Environmental Studies in New York State
385. The Value Added From <i>Candida auris</i> Point Prevalence and Environmental Studies in New York State Open
BACKGROUND: As of March 25 2018, 151 clinical cases of C. auris were diagnosed in NYS. We conducted point prevalence surveys (PPS) and environmental surveys (ES) to detect surveillance cases and assess the burden of environmental contamina…
View article: <i>Candida auris</i>in Healthcare Facilities, New York, USA, 2013–2017
<i>Candida auris</i>in Healthcare Facilities, New York, USA, 2013–2017 Open
Candida auris is an emerging yeast that causes healthcare-associated infections. It can be misidentified by laboratories and often is resistant to antifungal medications. We describe an outbreak of C. auris infections in healthcare facilit…